Catherine Dinauer, MD

• Manju Prasad
• Pei Hui
• Rita Abi-Raad
• Sacit Bulent Omay
• Zeynep Erson Omay

Carcinoma, Papillary; Congenital Hypothyroidism; Graves Disease; Hyperthyroidism; Pediatrics; Thyroid Gland; Thyroid Neoplasms

• Differences in the management of thyroid nodules in children and adolescents as compared to adultsGoldfarb M, Dinauer C. Differences in the management of thyroid nodules in children and adolescents as compared to adults. Current Opinion In Endocrinology Diabetes And Obesity 2022, 29: 466-473. PMID: 35777975, DOI: 10.1097/med.0000000000000754.
• Treatment of hypothyroidism in infants, children and adolescentsRodriguez L, Dinauer C, Francis G. Treatment of hypothyroidism in infants, children and adolescents. Trends In Endocrinology And Metabolism 2022, 33: 522-532. PMID: 35537910, DOI: 10.1016/j.tem.2022.04.007.
• Management of Pediatric Graves DiseaseQuintanilla-Dieck L, Khalatbari HK, Dinauer CA, Rastatter JC, Chelius DC, Katowitz WR, Shindo ML, Parisi MT, Kazahaya K. Management of Pediatric Graves Disease. JAMA Otolaryngology - Head & Neck Surgery 2021, 147: 1110-1118. PMID: 34647991, DOI: 10.1001/jamaoto.2021.2715.
• A Comparison of the Differences Between Dutch and American Thyroid Association Guidelines for the Management of Pediatric Thyroid CancerDinauer C. A Comparison of the Differences Between Dutch and American Thyroid Association Guidelines for the Management of Pediatric Thyroid Cancer. Clinical Thyroidology 2020, 32: 525-528. DOI: 10.1089/ct.2020;32.525-528.
• Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology–histopathology correlation in 7 patientsDarbinyan A, Morotti R, Cai G, Prasad ML, Christison‐Lagay E, Dinauer C, Adeniran AJ. Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology–histopathology correlation in 7 patients. Cancer Cytopathology 2020, 128: 746-756. PMID: 32897650, DOI: 10.1002/cncy.22329.
• Total Thyroidectomy Remains Appropriate as Initial Treatment for Children with Papillary Thyroid Cancer That Frequently Harbors Occult Bilateral DiseaseDinauer C. Total Thyroidectomy Remains Appropriate as Initial Treatment for Children with Papillary Thyroid Cancer That Frequently Harbors Occult Bilateral Disease. Clinical Thyroidology 2020, 32: 333-336. DOI: 10.1089/ct.2020;32.333-336.
• Pediatric differentiated thyroid carcinoma: An update from the APSA Cancer CommitteeChristison-Lagay ER, Baertschiger RM, Dinauer C, Francis G, Malek M, Lautz T, Aldrink J, Grant C, Rhee D, Ehrlich P, Dasgupta R, Abdessalam S, Committee O. Pediatric differentiated thyroid carcinoma: An update from the APSA Cancer Committee. Journal Of Pediatric Surgery 2020, 55: 2273-2283. PMID: 32553450, DOI: 10.1016/j.jpedsurg.2020.05.003.
• “A Real Pain in the Neck”Joseph K, Dinauer C. “A Real Pain in the Neck”. Clinical Thyroidology 2020, 32: 251-254. DOI: 10.1089/ct.2020;32.251-254.
• Large-scale second-hit AIP deletion causing a pediatric growth hormone-secreting pituitary adenoma: Case report and review of literatureGummadavelli A, Dinauer C, McGuone D, Vining EM, Erson-Omay EZ, Omay SB. Large-scale second-hit AIP deletion causing a pediatric growth hormone-secreting pituitary adenoma: Case report and review of literature. Journal Of Clinical Neuroscience 2020, 78: 420-422. PMID: 32336638, DOI: 10.1016/j.jocn.2020.04.103.
• Postoperative Preablation TSH-Stimulated Thyroglobulin May Predict Outcome of Differentiated Thyroid Cancer in ChildrenDinauer C. Postoperative Preablation TSH-Stimulated Thyroglobulin May Predict Outcome of Differentiated Thyroid Cancer in Children. Clinical Thyroidology 2020, 32: 131-134. DOI: 10.1089/ct.2020;32.131-134.
• Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume PracticeRubinstein JC, Herrick-Reynolds K, Dinauer C, Morotti R, Solomon D, Callender GG, Christison-Lagay ER. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice. Journal Of Surgical Research 2020, 249: 58-66. PMID: 31923715, DOI: 10.1016/j.jss.2019.12.002.
• The Block-and-Replace Method May Have a Role in the Management of Pediatric Graves’ DiseaseDinauer C. The Block-and-Replace Method May Have a Role in the Management of Pediatric Graves’ Disease. Clinical Thyroidology 2020, 32: 17-19. DOI: 10.1089/ct.2020;32.17-19.
• Children with Autoimmune Thyroid Disease Are at Increased Risk for Autoimmune GastritisDinauer C. Children with Autoimmune Thyroid Disease Are at Increased Risk for Autoimmune Gastritis. Clinical Thyroidology 2019, 31: 463-466. DOI: 10.1089/ct.2019;31.463-466.
• The Hypothalamic–Pituitary–Thyroid Axis Matures Earlier in Girls than in BoysDinauer C. The Hypothalamic–Pituitary–Thyroid Axis Matures Earlier in Girls than in Boys. Clinical Thyroidology 2019, 31: 365-367. DOI: 10.1089/ct.2019;31.365-367.
• Complication Rates for Pediatric Thyroid Surgery Are Lower at Higher-Volume U.S. HospitalsDinauer C. Complication Rates for Pediatric Thyroid Surgery Are Lower at Higher-Volume U.S. Hospitals. Clinical Thyroidology 2019, 31: 237-239. DOI: 10.1089/ct.2019;31.237-239.
• Malignancy Rates in Cytologically Indeterminate Thyroid Nodules among Children Are Lower Than Previously Reported but Remain Higher Than in AdultsDinauer C. Malignancy Rates in Cytologically Indeterminate Thyroid Nodules among Children Are Lower Than Previously Reported but Remain Higher Than in Adults. Clinical Thyroidology 2019, 31: 158-161. DOI: 10.1089/ct.2019;31.158-161.
• The Value of Thyroid-Function Testing in the Pediatric Inpatient Setting Is LowDinauer C. The Value of Thyroid-Function Testing in the Pediatric Inpatient Setting Is Low. Clinical Thyroidology 2019, 31: 52-54. DOI: 10.1089/ct.2019;31.52-54.
• Two-Hit Germline and Somatic AIP Mutations in a Pediatric Growth Hormone-Secreting Pituitary AdenomaFreedman I, Gummadavelli A, Mccarthy L, Spencer D, Fisayo A, Dinauer C, Vining E, Erson-Omay E, Omay S. Two-Hit Germline and Somatic AIP Mutations in a Pediatric Growth Hormone-Secreting Pituitary Adenoma. Journal Of Neurological Surgery Part B Skull Base 2019, 80: s1-s244. DOI: 10.1055/s-0039-1679833.
• Lymph node ratio predicts recurrence in pediatric papillary thyroid cancerRubinstein JC, Dinauer C, Herrick-Reynolds K, Morotti R, Callender GG, Christison-Lagay ER. Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer. Journal Of Pediatric Surgery 2018, 54: 129-132. PMID: 30361076, DOI: 10.1016/j.jpedsurg.2018.10.010.
• Use of Ultrasound for Prognostication and Surgical Decision-making in Pediatric Papillary Thyroid Cancer*Herrick-Reynolds K, Rubinstein J, Dinauer C, Hammers L, Prasad M, Morotti R, Udelsman R, Christison-Lagay E. Use of Ultrasound for Prognostication and Surgical Decision-making in Pediatric Papillary Thyroid Cancer*. Pediatrics 2018, 141: 762-762. DOI: 10.1542/peds.141.1ma8.762.
• Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup ConsortiumClement SC, Kremer LCM, Verburg FA, Simmons JH, Goldfarb M, Peeters RP, Alexander EK, Bardi E, Brignardello E, Constine LS, Dinauer CA, Drozd VM, Felicetti F, Frey E, Heinzel A, van den Heuvel-Eibrink MM, Huang SA, Links TP, Lorenz K, Mulder RL, Neggers SJ, van Dijkum E, Oeffinger KC, van Rijn RR, Rivkees SA, Ronckers CM, Schneider AB, Skinner R, Wasserman JD, Wynn T, Hudson MM, Nathan PC, van Santen HM. Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Cancer Treatment Reviews 2017, 63: 28-39. PMID: 29202445, DOI: 10.1016/j.ctrv.2017.11.005.
• The Pediatric Thyroid Nodule and Papillary Thyroid Cancer ManagementRivkees S, Dinauer C. The Pediatric Thyroid Nodule and Papillary Thyroid Cancer Management. 2017, 199-216. DOI: 10.1007/978-3-319-43618-0_13.
• Pathologic Characteristics, Natural History, and Prognostic Implications of BRAFV600E Mutation in Pediatric Papillary Thyroid CarcinomaHardee S, Prasad ML, Hui P, Dinauer CA, Morotti RA. Pathologic Characteristics, Natural History, and Prognostic Implications of BRAFV600E Mutation in Pediatric Papillary Thyroid Carcinoma. Pediatric And Developmental Pathology 2017, 20: 206-212. PMID: 28521635, DOI: 10.1177/1093526616689628.
• NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United StatesPrasad ML, Vyas M, Horne MJ, Virk RK, Morotti R, Liu Z, Tallini G, Nikiforova MN, Christison-Lagay ER, Udelsman R, Dinauer CA, Nikiforov YE. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States. Cancer 2016, 122: 1097-1107. PMID: 26784937, DOI: 10.1002/cncr.29887.
• Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid CancerFrancis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2015, 25: 716-759. PMID: 25900731, PMCID: PMC4854274, DOI: 10.1089/thy.2014.0460.
• C-Cell Neoplasia in Asymptomatic Carriers of RET Mutation in Extracellular Cysteine-Rich and Intracellular Tyrosine Kinase DomainAbi-Raad R, Virk RK, Dinauer CA, Prasad A, Morotti RA, Breuer CK, Sosa JA, Udelsman R, Rivkees SA, Prasad ML. C-Cell Neoplasia in Asymptomatic Carriers of RET Mutation in Extracellular Cysteine-Rich and Intracellular Tyrosine Kinase Domain. Human Pathology 2015, 46: 1121-1128. PMID: 26033033, DOI: 10.1016/j.humpath.2015.04.011.
• Differentiated thyroid cancer in childrenBauer A, Francis G, Waguespack S, Dinauer C. Differentiated thyroid cancer in children. 2013, 106-118. DOI: 10.2217/ebo.12.534.
• Differentiated thyroid cancer in childrenin Clinical Management of Thyroid Cancer, ed. Kakudo K and Liu Z, Future Medicine, London, UK, 2013, pp 106-118 (e-book).
• The Treatment of Differentiated Thyroid Cancer in Children: Emphasis on Surgical Approach and Radioactive Iodine TherapyRivkees SA, Mazzaferri EL, Verburg FA, Reiners C, Luster M, Breuer CK, Dinauer CA, Udelsman R. The Treatment of Differentiated Thyroid Cancer in Children: Emphasis on Surgical Approach and Radioactive Iodine Therapy. Endocrine Reviews 2011, 32: 798-826. PMID: 21880704, PMCID: PMC3591676, DOI: 10.1210/er.2011-0011.
• Adverse Events Associated with Methimazole Therapy of Graves' Disease in ChildrenRivkees SA, Stephenson K, Dinauer C. Adverse Events Associated with Methimazole Therapy of Graves' Disease in Children. International Journal Of Pediatric Endocrinology 2010, 2010: 176970. PMID: 20224800, PMCID: PMC2833412, DOI: 10.1155/2010/176970.
• Adverse Events Associated with Methimazole Therapy of Graves' Disease in ChildrenRivkees S, Stephenson K, Dinauer C. Adverse Events Associated with Methimazole Therapy of Graves' Disease in Children. International Journal Of Pediatric Endocrinology 2010, 2010: 176970. DOI: 10.1186/1687-9856-2010-176970.
• Chapter 98 The Use of 131Iodine in the Treatment of Graves’ Disease in ChildrenRivkees S, Dinauer C. Chapter 98 The Use of 131Iodine in the Treatment of Graves’ Disease in Children. 2009, 942-955. DOI: 10.1016/b978-0-12-374135-6.00098-4.
• The Use of 131-Iodine in the Treatment of Graves Disease in Childrenin Comprehensive Handbook of Iodine: Nutritional, Endocrine, and Pathological Aspects, ed. Preedy VR, Burrow GN, and Watson RR, Elsevier Inc., Oxford, UK, 2009, pp 943-955.
• Differentiated thyroid cancer in children: diagnosis and managementDinauer CA, Breuer C, Rivkees SA. Differentiated thyroid cancer in children: diagnosis and management. Current Opinion In Oncology 2008, 20: 59-65. PMID: 18043257, DOI: 10.1097/cco.0b013e3282f30220.
• Thyroid Cancer in ChildrenDinauer C, Francis GL. Thyroid Cancer in Children. Endocrinology And Metabolism Clinics Of North America 2007, 36: 779-806. PMID: 17673128, DOI: 10.1016/j.ecl.2007.04.002.
• An optimal treatment for pediatric Graves' disease is radioiodine.Rivkees SA, Dinauer C. An optimal treatment for pediatric Graves' disease is radioiodine. The Journal Of Clinical Endocrinology & Metabolism 2007, 92: 797-800. PMID: 17341574, DOI: 10.1210/jc.2006-1239.
• The MACIS Score Predicts the Clinical Course of Papillary Thyroid Carcinoma in Children and AdolescentsPowers PA, Dinauer CA, Tuttle RM, Francis GL. The MACIS Score Predicts the Clinical Course of Papillary Thyroid Carcinoma in Children and Adolescents. Journal Of Pediatric Endocrinology And Metabolism 2004, 17: 339-344. PMID: 15112910, DOI: 10.1515/jpem.2004.17.3.339.
• Treatment of Recurrent Papillary Thyroid Carcinoma in Children and AdolescentsPowers PA, Dinauer CA, Tuttle RM, Francis GL. Treatment of Recurrent Papillary Thyroid Carcinoma in Children and Adolescents. Journal Of Pediatric Endocrinology And Metabolism 2003, 16: 1033-1040. PMID: 14513881, DOI: 10.1515/jpem.2003.16.7.1033.
• Tumor Size and Extent of Disease at Diagnosis Predict the Response to Initial Therapy for Papillary Thyroid Carcinoma in Children and AdolescentsPowers PA, Dinauer CA, Tuttle RM, Robie DK, McClellan DR, Francis GL. Tumor Size and Extent of Disease at Diagnosis Predict the Response to Initial Therapy for Papillary Thyroid Carcinoma in Children and Adolescents. Journal Of Pediatric Endocrinology And Metabolism 2003, 16: 693-702. PMID: 12880118, DOI: 10.1515/jpem.2003.16.5.693.
• Differentiated Thyroid Carcinoma That Express Sodium-Iodide Symporter Have a Lower Risk of Recurrence for Children and AdolescentsPatel A, Jhiang S, Dogra S, Terrell R, Powers PA, Fenton C, Dinauer CA, Tuttle RM, Francis GL. Differentiated Thyroid Carcinoma That Express Sodium-Iodide Symporter Have a Lower Risk of Recurrence for Children and Adolescents. Pediatric Research 2002, 52: 737-744. PMID: 12409522, DOI: 10.1203/00006450-200211000-00021.
• Nitrotyrosine, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) are increased in thyroid tumors from children and adolescentsPatel A, Fenton C, Terrell R, Powers P, Dinauer C, Tuttle R, Francis G. Nitrotyrosine, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) are increased in thyroid tumors from children and adolescents. Journal Of Endocrinological Investigation 2002, 25: 675-683. PMID: 12240898, DOI: 10.1007/bf03345100.
• Intense Expression of the B7-2 Antigen Presentation Coactivator Is an Unfavorable Prognostic Indicator for Differentiated Thyroid Carcinoma of Children and AdolescentsShah R, Banks K, Patel A, Dogra S, Terrell R, Powers PA, Fenton C, Dinauer CA, Tuttle RM, Francis GL. Intense Expression of the B7-2 Antigen Presentation Coactivator Is an Unfavorable Prognostic Indicator for Differentiated Thyroid Carcinoma of Children and Adolescents. The Journal Of Clinical Endocrinology & Metabolism 2002, 87: 4391-4397. PMID: 12213904, DOI: 10.1210/jc.2002-011262.
• Matrix metalloproteinase (MMP) expression by differentiated thyroid carcinoma of children and adolescentsPatel A, Straight A, Mann H, Duffy E, Fenton C, Dinauer C, Tuttle R, Francis G. Matrix metalloproteinase (MMP) expression by differentiated thyroid carcinoma of children and adolescents. Journal Of Endocrinological Investigation 2002, 25: 403-408. PMID: 12035934, DOI: 10.1007/bf03344028.
• Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescentsStraight A, Patel A, Fenton C, Dinauer C, Tuttle R, Francis G. Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents. Journal Of Endocrinological Investigation 2002, 25: 302-308. PMID: 12030599, DOI: 10.1007/bf03344009.
• Infiltration of Differentiated Thyroid Carcinoma by Proliferating Lymphocytes Is Associated with Improved Disease-Free Survival for Children and Young AdultsGupta S, Patel A, Folstad A, Fenton C, Dinauer C, Tuttle R, Conran R, Francis G. Infiltration of Differentiated Thyroid Carcinoma by Proliferating Lymphocytes Is Associated with Improved Disease-Free Survival for Children and Young Adults. The Journal Of Clinical Endocrinology & Metabolism 2001, 86: 1346-1354. PMID: 11238531, DOI: 10.1210/jcem.86.3.7310.
• Over‐expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinomaRamirez R, Hsu D, Patel A, Fenton C, Dinauer C, Tuttle R, Francis G. Over‐expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma. Clinical Endocrinology 2000, 53: 635-644. PMID: 11106926, DOI: 10.1046/j.1365-2265.2000.01124.x.
• The Expression of Vascular Endothelial Growth Factor and the Type 1 Vascular Endothelial Growth Factor Receptor Correlate with the Size of Papillary Thyroid Carcinoma in Children and Young AdultsFenton C, Patel A, Dinauer C, Robie D, Tuttle R, Francis G. The Expression of Vascular Endothelial Growth Factor and the Type 1 Vascular Endothelial Growth Factor Receptor Correlate with the Size of Papillary Thyroid Carcinoma in Children and Young Adults. Thyroid 2000, 10: 349-357. PMID: 10807064, DOI: 10.1089/thy.2000.10.349.
• Tyrosine kinase expression is increased in papillary thyroid carcinoma of children and young adults.Patel A, Fenton C, Ramirez R, Dinauer CA, Tuttle RM, Nikiforov YE, Gary FL. Tyrosine kinase expression is increased in papillary thyroid carcinoma of children and young adults. Frontiers In Bioscience-Landmark 2000, 5: a1-9. PMID: 10702379, DOI: 10.2741/patel.
• Extensive surgery improves recurrence-free survival for children and young patients with class I papillary thyroid carcinomaDinauer C, Tuttle R, Robie D, McClellan D, Francis G. Extensive surgery improves recurrence-free survival for children and young patients with class I papillary thyroid carcinoma. Journal Of Pediatric Surgery 1999, 34: 1799-1804. PMID: 10626858, DOI: 10.1016/s0022-3468(99)90316-0.
• Ras mutations are uncommon in sporadic thyroid cancer in children and young adultsFenton C, Anderson J, Lukes Y, Dinauer C, Tuttle RM, Francis GL. Ras mutations are uncommon in sporadic thyroid cancer in children and young adults. Journal Of Endocrinological Investigation 1999, 22: 781-789. PMID: 10614528, DOI: 10.1007/bf03343644.
• Over-Expression of c-MET Is Associated with Increased Recurrence in Childhood Thyroid CancerRamirez R, Fenton C, Patel A, Dinauer C, Tuttle R, Francis G. Over-Expression of c-MET Is Associated with Increased Recurrence in Childhood Thyroid Cancer. Pediatric Research 1999, 45: 96-96. DOI: 10.1203/00006450-199904020-00574.
• The ret/PTC Mutations are Common in Sporadic Papillary Thyroid Cancer in ChildrenFenton C, Lukes Y, Dinauer C, Tuttle R, Francis G. The ret/PTC Mutations are Common in Sporadic Papillary Thyroid Cancer in Children. Pediatric Research 1999, 45: 89-89. DOI: 10.1203/00006450-199904020-00529.
• Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adultsDinauer C, Tuttle M, Robie D, McClellan D, Svec R, Adair C, Francis G. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clinical Endocrinology 1998, 49: 619-628. PMID: 10197078, DOI: 10.1046/j.1365-2265.1998.00584.x.
• The impact of initial surgical management on outcome in young patients with differentiated thyroid cancer.Robie DK, Dinauer CW, Tuttle RM, Ward DT, Parry R, McClellan D, Svec R, Adair C, Francis G. The impact of initial surgical management on outcome in young patients with differentiated thyroid cancer. Journal Of Pediatric Surgery 1998, 33: 1134-8; discussion 1139-40. PMID: 9694109, DOI: 10.1016/s0022-3468(98)90546-2.
• Metronidazole: Long Term Therapy for Methylmalonic Acidemia? 742Dinauer C, Camp K, Rennert O, Francis G. Metronidazole: Long Term Therapy for Methylmalonic Acidemia? 742. Pediatric Research 1998, 43: 129-129. DOI: 10.1203/00006450-199804001-00763.
• Aggressive Surgical Therapy Improves Disease Free Survival in Children with Class 1 Papillary Thyroid Cancer † 499Dinauer C, Tuttle R, Robie D, McClellan D, Francis G. Aggressive Surgical Therapy Improves Disease Free Survival in Children with Class 1 Papillary Thyroid Cancer † 499. Pediatric Research 1998, 43: 88-88. DOI: 10.1203/00006450-199804001-00520.
• The Extent of Disease at Diagnosis Predicts Response to Initial Therapy for Papillary Thyroid Cancer. † 498Dinauer C, Tuttle R, Robie D, McClellan D, Francis G. The Extent of Disease at Diagnosis Predicts Response to Initial Therapy for Papillary Thyroid Cancer. † 498. Pediatric Research 1998, 43: 87-87. DOI: 10.1203/00006450-199804001-00519.
• Circumcision in children beyond the neonatal period.Wiswell TE, Tencer HL, Welch CA, Chamberlain JL. Circumcision in children beyond the neonatal period. Pediatrics 1993, 92: 791-3. PMID: 8233738.